News

Our 3-day PentaTr@ining Namibia 2024 residential course came to a close on July 4th 2024. The course was organised in partnership with several key stakeholders, including the Namibia HIV Clinicians…

Laurus Labs has submitted an application to the US Food and Drug Administration (FDA) for the tentative approval of paediatric Darunavir/ritonavir (pDRV/r (120/20 mg)). UNIVERSAL is the first product development…

Analytical treatment interruption (ATI) is a crucial component of HIV cure research, but discussions have largely focused on adult populations. A recent expert opinion from the EPIICAL consortium,

We are thrilled to announce the release of the Action Plan “Accelerating bnAbs for Peri- and Post-Natal HIV Prophylaxis”. Developed by a Task Force of leading experts and stakeholders,

This World Hepatitis Day, with the theme “It’s Time for Action,” let’s turn our focus to underserved and often overlooked populations in the fight against this preventable disease, children and…

Arriving at the International Workshop on Pediatrics & HIV 2024, we felt a mix of nerves and excitement, knowing we were about to be surrounded by experts who spend their…

The PediCAP trial team is pleased to announce the successful completion of a series of dissemination meetings aimed at sharing trial results with key stakeholders in Mozambique. These meetings targeted…

A new collaborative project called SUPPORT has officially launched to train the next generation of researchers who will focus on preventing mortality among these children. The SUPPORT initiative,

From 14 to 16 May, 2024, PentaTr@ining in collaboration with UNICEF, the World Health Organization (WHO) and with support from the International Organization for Migration (IOM),

The European Commission has granted a 15-month extension to the RBDCOV project, allowing researchers additional time to recruit volunteers for the HH-3 clinical trial. This trial assesses the efficacy,

Last week, the VERDI project team gathered in Tallinn, Estonia, and online for the 4th General Assembly. This year’s meeting, which brought together around 60 people from 30 partner institutions,

We are pleased to announce that the poster “SARS-CoV-2 Infection Incidence and Severity in Immunocompromised Children: A Population-Based Study in Italy and Norway” has received the Best Poster Award from the ESPID Committee for…

Padova, 3 June 2024 – A new European multicenter study, named NeoDeco, will investigate whether optimised kangaroo care can reduce infection rates in preterm babies in neonatal intensive care units…

We are pleased to announce the successful completion of recruitment for the HVRRICANE study. The study, a collaboration between Penta, Bambino Gesù Paediatric Hospital in Rome (OPBG),

EPIICAL’s EARTH Study reveals challenges persist for infants in Africa with HIV despite early treatment The EARTH study findings published in eClinical Medicine shed light on the ongoing struggle for…

This article originally appeared on Horizon: The EU Research & Innovation Magazine. In the 1980s, during the height of the AIDS epidemic,

The PediCAP consortium, a global partnership of 14 institutions, presented promising results from its main trial, PediCAP-A, at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global) conference…

Today marks International Kangaroo Care Awareness Day – an important day dedicated to raising awareness of the benefits of skin-to-skin contact on newborns, especially those born prematurely.  Prematurity is a…